RecruitingNCT05556928

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

Sponsor

University of Alabama at Birmingham

Enrollment

5,000 participants

Start Date

Jul 21, 2020

Study Type

OBSERVATIONAL

Conditions

Multiple Myeloma Amyloidosis Plasma Cell Leukemia

Summary

The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is building a registry of older adults with blood cancers (such as leukemia, lymphoma, or myeloma) to understand how aging and resilience affect treatment outcomes. Researchers want to identify which older patients can tolerate intensive treatment and which may need gentler approaches. **You may be eligible if:** - You are 50 years old or older - You have a confirmed diagnosis of a blood cancer such as multiple myeloma, leukemia, lymphoma, or a related blood disorder - You are receiving care at UAB (including as an inpatient) **You may NOT be eligible if:** - You are under 50 years old - You do not read or speak English (many of the questionnaires are not validated in other languages) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.